References
- Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD . Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116:488–98.
- Nienhuis HL, de Leeuw K, Smit AJ, Bijzet J, Stegeman CA, Kallenberg CG Enhanced endothelium-dependent microvascular responses in patients with Wegener’s granulomatosis. J Rheumatol 2007;34:1875–81.
- Petrie MC, Padmanabhan N, McDonald JE, Hillier C, Connell JM, McMurray JJ. Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease. J Am Coll Cardiol 2001;37:1056–61.
- Li M, Liu K, Michalicek J, Angus JA, Hunt JE, Dell’Italia LJ, . Involvement of chymase-mediated angiotensin II generation in blood pressure regulation. J Clin Invest 2004;114:112–20.
- Kumar R, Singh VP, Baker KM. The intracellular renin-angiotensin system: implications in cardiovascular remodeling. Curr Opin Nephrol Hypertens 2008;17:168–73.
- Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 2007;292:C82–97.
- Bloch DA, Michel BA, Hunder GG, McShane DJ, Arend WP, Calabrese LH, The American College of Rheumatology 1990 criteria for the classification of vasculitis. Patients and methods. Arthritis Rheum 1990;33:1068–73.
- Dimitrijevic I, Malmsjo M, Andersson C, Rissler P, Edvinsson L. Increased angiotensin II type 1 receptor expression in temporal arteries from patients with giant cell arteritis. Ophthalmology 2009;116:990–6.
- Unger T, Chung O, Csikos T, Culman J, Gallinat S, Gohlke P, Angiotensin receptors. J Hypertens 1996;14(Suppl 5):S95–103.
- Wassmann S, Nickenig G. Pathophysiological regulation of the AT1-receptor and implications for vascular disease. J Hypertens Suppl 2006;24:S15–21.
- Sasamura H, Nakazato Y, Hayashida T, Kitamura Y, Hayashi M, Saruta T. Regulation of vascular type 1 angiotensin receptors by cytokines. Hypertension 1997;30:35–41.
- Wang CH, Li SH, Weisel RD, Fedak PW, Dumont AS, Szmitko P, C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation 2003;107: 1783–90.
- Huugen D, Tervaert JW, Heeringa P. TNF-alpha bioactivity-inhibiting therapy in ANCA-associated vasculitis: clinical and experimental considerations. Clin J Am Soc Nephrol 2006;1:1100–7.